메뉴 건너뛰기
Clinical and Translational Science
Volumn 2, Issue 2, 2009, Pages 96-97
Translational medicine in the era of health care reform
Author keywords

[No Author keywords available]
Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DRUG COST; DRUG RESEARCH; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE SYSTEM; LABORATORY DIAGNOSIS; MEDICAL PRACTICE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RESOURCE ALLOCATION; RISK BENEFIT ANALYSIS; ECONOMICS; HUMAN; TRANSLATIONAL RESEARCH;
EID: 77953442451     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2009.00104.x     Document Type: Article
Times cited : (11)
References (14)
  • 1
    • 49149101782 scopus 로고    scopus 로고
    • The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace
    • Sollano JA, Kirsch JM, Bala MV, Chambers MG, Harpole LH. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace. Clin Pharmacol Ther. 2008; 84: 263-266.
    • (2008) Clin Pharmacol Ther , vol.84 , pp. 263-266
    • Sollano, J.A.1    Kirsch, J.M.2    Bala, M.V.3    Chambers, M.G.4    Harpole, L.H.5
  • 2
    • 49149109126 scopus 로고    scopus 로고
    • Using pharmacoeconomics to value pharmacotherapy
    • Hay JW. Using pharmacoeconomics to value pharmacotherapy. Clin Pharmacol Ther. 2008; 84: 197-200.
    • (2008) Clin Pharmacol Ther , vol.84 , pp. 197-200
    • Hay, J.W.1
  • 3
    • 49149097133 scopus 로고    scopus 로고
    • Pharmacoeconomics is coming of age
    • Pizzi L, Singh V. Pharmacoeconomics is coming of age. Clin Pharmacol Ther. 2008; 84: 188-190.
    • (2008) Clin Pharmacol Ther , vol.84 , pp. 188-190
    • Pizzi, L.1    Singh, V.2
  • 4
    • 57449092873 scopus 로고    scopus 로고
    • An unwelcome side effect of direct-to-consumer personal genome testing: Raiding the medical commons
    • McGuire AL, Burke W. An unwelcome side effect of direct-to-consumer personal genome testing: Raiding the medical commons. JAMA. 2008; 300: 2669-2671.
    • (2008) JAMA , vol.300 , pp. 2669-2671
    • McGuire, A.L.1    Burke, W.2
  • 5
    • 77953472786 scopus 로고    scopus 로고
    • Clinical and translational science: At the intersection of molecular and individualized medicine
    • Waldman SA, Terzic A. Clinical and translational science: At the intersection of molecular and individualized medicine. Clin Transl Sci. 2008; 1: 6-8.
    • (2008) Clin Transl Sci , vol.1 , pp. 6-8
    • Waldman, S.A.1    Terzic, A.2
  • 6
    • 33847690276 scopus 로고    scopus 로고
    • The art and science of personalized medicine
    • Piquette-Miller M, Grant DM. The art and science of personalized medicine. Clin Pharmacol Ther. 2007; 81: 311-315.
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 311-315
    • Piquette-Miller, M.1    Grant, D.M.2
  • 7
    • 34548702881 scopus 로고    scopus 로고
    • Molecular medicine hones therapeutic arts to science
    • Waldman SA, Terzic MR, Terzic A. Molecular medicine hones therapeutic arts to science. Clin Pharmacol Ther. 2007; 82: 343-347.
    • (2007) Clin Pharmacol Ther , vol.82 , pp. 343-347
    • Waldman, S.A.1    Terzic, M.R.2    Terzic, A.3
  • 8
    • 33846600867 scopus 로고    scopus 로고
    • Paving the critical path: How can clinical pharmacology help achieve the vision?
    • Lesko LJ. Paving the critical path: How can clinical pharmacology help achieve the vision? Clin Pharmacol Ther. 2007; 81: 170-177.
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 170-177
    • Lesko, L.J.1
  • 9
    • 33846646004 scopus 로고    scopus 로고
    • The prospects for "personalized medicine"in drug development and drug therapy
    • Woodcock J. The prospects for "personalized medicine"in drug development and drug therapy. Clin Pharmacol Ther. 2007; 81: 164-169.
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 164-169
    • Woodcock, J.1
  • 10
    • 35448958119 scopus 로고    scopus 로고
    • A vision of individualized medicine in the context of global health
    • Cortese DA. A vision of individualized medicine in the context of global health. Clin Pharmacol Ther. 2007; 82: 491-493.
    • (2007) Clin Pharmacol Ther , vol.82 , pp. 491-493
    • Cortese, D.A.1
  • 11
    • 33845974419 scopus 로고    scopus 로고
    • Biomarkers and surrogate end points for fit-forpurpose development and regulatory evaluation of new drugs
    • Wagner JA, Williams SA, Webster CJ. Biomarkers and surrogate end points for fit-forpurpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther. 2007; 81: 104-107.
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 104-107
    • Wagner, J.A.1    Williams, S.A.2    Webster, C.J.3
  • 12
    • 49149106431 scopus 로고    scopus 로고
    • Pharmacoeconomics in the era of individualized medicine
    • Waldman SA, Terzic A. Pharmacoeconomics in the era of individualized medicine. Clin Pharmacol Ther. 2008; 84: 179-182.
    • (2008) Clin Pharmacol Ther , vol.84 , pp. 179-182
    • Waldman, S.A.1    Terzic, A.2
  • 14
    • 37349116252 scopus 로고    scopus 로고
    • The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?
    • Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007; 9: 665-674.
    • (2007) Genet Med , vol.9 , pp. 665-674
    • Khoury, M.J.1    Gwinn, M.2    Yoon, P.W.3    Dowling, N.4    Moore, C.A.5    Bradley, L.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.